MUSTANG BIO, INC. Balance Sheet
MBIO|4 years of annual SEC 10-K data (FY2016-FY2019)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
MUSTANG BIO, INC. had $73M in total assets and $36M in shareholders' equity as of FY2019.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|
| Cash & Equivalents | $61.4M | - | - | - |
| Current Assets | $63.1M | $35.1M | $61.4M | $27.5M |
| PP&E (Net) | $7.9M | $6.9M | - | - |
| Total Assets | $73.4M | $42.8M | $63.5M | $27.5M |
| Current Liabilities | $7.8M | $5.6M | $3.6M | $3.2M |
| Shareholders' Equity | $36.4M | $59.8M | $24.3M | -$4.1M |